November 14th, 2024
In a significant move to support New Zealanders requiring specialist health treatment, Health Minister Dr Shane Reti has announced an $18 million funding boost to the National Travel Assistance (NTA) scheme. This enhancement aims to aid individuals traveling for essential medical care, addressing the financial strain on families during a cost-of-living crisis.
The big picture:
The funding increase is the first for the NTA scheme since 2009, highlighting a long-standing need for updating the support provided to New Zealand residents.
Approximately 4,500 New Zealanders are expected to benefit from the updated scheme, which includes increased mileage and accommodation rates, easier pre-payment and claiming options, and expanded eligibility criteria.
Zoom in:
Mileage and accommodation rates: The mileage reimbursement rate will rise from 28 cents to 34 cents per kilometre. Accommodation rates will see a significant increase from $100 to $140 per night, with the rate for staying with friends or family also going up from $25 to $35 a night.
Claiming process: Efforts to streamline the claiming process include the introduction of more online options and a pilot for pre-payment options. This aims to reduce the bureaucratic hurdles previously experienced by claimants.
What they're saying:
Dr Reti acknowledged the delay in updating the scheme and thanked the Cancer Society and other NGOs for their advocacy, which played a crucial role in driving these changes.
The Health Minister emphasized that the government's goal is to remove barriers to treatment, ensuring timely and effective care for all New Zealanders.
What's next:
The initial phase of the scheme enhancements, including the rate increases and the introduction of an easier email claiming option, is set to roll out from 1 April 2024. Further changes will be implemented in tranches to ensure a smooth transition for all stakeholders.
Between the lines:
This update to the NTA scheme reflects a broader commitment by the coalition government to improve health outcomes across New Zealand by making treatments more accessible and affordable, especially during challenging economic times.